FDA regulation of dietary supplements and requirements regarding adverse event reporting
- PMID: 20032973
- DOI: 10.1038/clpt.2009.263
FDA regulation of dietary supplements and requirements regarding adverse event reporting
Abstract
In 1994, the Dietary Supplement Health and Education Act (DSHEA) amended the Federal Food, Drug, and Cosmetic Act (FDC Act) to set up a distinct regulatory framework for what we now call dietary supplements. The DSHEA was passed with the intent of striking a balance between providing consumers access to safe dietary supplements to help maintain or improve their health and giving the US Food and Drug Administration (FDA) authority to regulate and take action against manufacturers of supplements or supplement ingredients that present safety problems, are presented with false or misleading claims, or are adulterated or misbranded. This article will present FDA's recent experience in collecting and evaluating dietary supplement adverse event data for the purpose of assuring the public that the dietary supplements they purchase are safe.
Similar articles
-
The importance of GRAS to the functional food and nutraceutical industries.Toxicology. 2006 Apr 3;221(1):17-27. doi: 10.1016/j.tox.2006.01.012. Epub 2006 Feb 17. Toxicology. 2006. PMID: 16483705
-
FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.Food Drug Law J. 2009;64(3):577-98. Food Drug Law J. 2009. PMID: 19999646
-
Dietary supplements and lessons to be learned from GRAS.Regul Toxicol Pharmacol. 2000 Feb;31(1):68-76. doi: 10.1006/rtph.1999.1369. Regul Toxicol Pharmacol. 2000. PMID: 10715226 Review.
-
Dietary supplement adverse event reports: review and analysis.Food Drug Law J. 2009;64(3):503-13. Food Drug Law J. 2009. PMID: 19999641
-
Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.Life Sci. 2006 Mar 27;78(18):2049-53. doi: 10.1016/j.lfs.2005.12.020. Epub 2006 Mar 3. Life Sci. 2006. PMID: 16516243 Review.
Cited by
-
A multi-detector analytical approach for characterizing complex botanical extracts: a case study on ashwagandha.Anal Bioanal Chem. 2025 Jul 22. doi: 10.1007/s00216-025-06006-8. Online ahead of print. Anal Bioanal Chem. 2025. PMID: 40695986
-
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended Approach.Drug Metab Dispos. 2018 Jul;46(7):1046-1052. doi: 10.1124/dmd.118.081273. Epub 2018 May 7. Drug Metab Dispos. 2018. PMID: 29735752 Free PMC article.
-
Intra-Laboratory Validation of Alpha-Galactosidase Activity Measurement in Dietary Supplements.Molecules. 2021 Mar 12;26(6):1566. doi: 10.3390/molecules26061566. Molecules. 2021. PMID: 33809185 Free PMC article.
-
Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling.Stud Health Technol Inform. 2017;245:614-618. Stud Health Technol Inform. 2017. PMID: 29295169 Free PMC article.
-
Chondroitin Sulfate in USA Dietary Supplements in Comparison to Pharma Grade Products: Analytical Fingerprint and Potential Anti-Inflammatory Effect on Human Osteoartritic Chondrocytes and Synoviocytes.Pharmaceutics. 2021 May 17;13(5):737. doi: 10.3390/pharmaceutics13050737. Pharmaceutics. 2021. PMID: 34067775 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous